Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 82

1.

Prognostic value of matrix Gla protein in breast cancer.

Yoshimura K, Takeuchi K, Nagasaki K, Ogishima S, Tanaka H, Iwase T, Akiyama F, Kuroda Y, Miki Y.

Mol Med Rep. 2009 Jul-Aug;2(4):549-53. doi: 10.3892/mmr_00000135.

PMID:
21475864
[PubMed]
2.

Purification of matrix Gla protein from a marine teleost fish, Argyrosomus regius: calcified cartilage and not bone as the primary site of MGP accumulation in fish.

Simes DC, Williamson MK, Ortiz-Delgado JB, Viegas CS, Price PA, Cancela ML.

J Bone Miner Res. 2003 Feb;18(2):244-59.

PMID:
12568402
[PubMed - indexed for MEDLINE]
3.

Developmental expression and hormonal regulation of the rat matrix Gla protein (MGP) gene in chondrogenesis and osteogenesis.

Barone LM, Owen TA, Tassinari MS, Bortell R, Stein GS, Lian JB.

J Cell Biochem. 1991 Aug;46(4):351-65.

PMID:
1757478
[PubMed - indexed for MEDLINE]
4.

Gene expression profiles of breast cancer obtained from core cut biopsies before neoadjuvant docetaxel, adriamycin, and cyclophoshamide chemotherapy correlate with routine prognostic markers and could be used to identify predictive signatures.

Rody A, Karn T, Gätje R, Kourtis K, Minckwitz G, Loibl S, Munnes M, Ruckhäberle E, Holtrich U, Kaufmann M, Ahr A.

Zentralbl Gynakol. 2006 Apr;128(2):76-81.

PMID:
16673249
[PubMed - indexed for MEDLINE]
5.

Differential regulation of matrix Gla protein (MGP) gene expression by retinoic acid and estrogen in human breast carcinoma cells.

Sheikh MS, Shao ZM, Chen JC, Fontana JA.

Mol Cell Endocrinol. 1993 Apr;92(2):153-60.

PMID:
8319825
[PubMed - indexed for MEDLINE]
6.

Prognostic value of NDRG1 and SPARC protein expression in breast cancer patients.

Nagai MA, Gerhard R, Fregnani JH, Nonogaki S, Rierger RB, Netto MM, Soares FA.

Breast Cancer Res Treat. 2011 Feb;126(1):1-14. doi: 10.1007/s10549-010-0867-2. Epub 2010 Apr 6.

PMID:
20369286
[PubMed - indexed for MEDLINE]
7.

Expression of the matrix Gla protein in urogenital malignancies.

Levedakou EN, Strohmeyer TG, Effert PJ, Liu ET.

Int J Cancer. 1992 Oct 21;52(4):534-7.

PMID:
1399132
[PubMed - indexed for MEDLINE]
8.

Down-regulation of matrix Gla protein messenger RNA in human colorectal adenocarcinomas.

Fan C, Sheu D, Fan H, Hsu K, Allen Chang C, Chan E.

Cancer Lett. 2001 Apr 10;165(1):63-9.

PMID:
11248420
[PubMed - indexed for MEDLINE]
9.

Matrix Gla protein gene expression and protein accumulation colocalize with cartilage distribution during development of the teleost fish Sparus aurata.

Pinto JP, Conceição N, Gavaia PJ, Cancela ML.

Bone. 2003 Mar;32(3):201-10.

PMID:
12667547
[PubMed - indexed for MEDLINE]
10.

Correlation of insulin-like growth factor-binding protein-3 messenger RNA with protein expression in primary breast cancer tissues: detection of higher levels in tumors with poor prognostic features.

Rocha RL, Hilsenbeck SG, Jackson JG, Lee AV, Figueroa JA, Yee D.

J Natl Cancer Inst. 1996 May 1;88(9):601-6.

PMID:
8609661
[PubMed - indexed for MEDLINE]
Free Article
12.

Astrocyte elevated gene-1 is a novel prognostic marker for breast cancer progression and overall patient survival.

Li J, Zhang N, Song LB, Liao WT, Jiang LL, Gong LY, Wu J, Yuan J, Zhang HZ, Zeng MS, Li M.

Clin Cancer Res. 2008 Jun 1;14(11):3319-26. doi: 10.1158/1078-0432.CCR-07-4054.

PMID:
18519759
[PubMed - indexed for MEDLINE]
Free Article
13.

Renal osteodystrophy: alpha-Heremans Schmid glycoprotein/fetuin-A, matrix GLA protein serum levels, and bone histomorphometry.

Coen G, Ballanti P, Balducci A, Grandi F, Manni M, Mantella D, Pierantozzi A, Ruggeri M, Sardella D, Sorbo G, Bonucci E.

Am J Kidney Dis. 2006 Jul;48(1):106-13.

PMID:
16797392
[PubMed - indexed for MEDLINE]
14.

Molecular structure, chromosome assignment, and promoter organization of the human matrix Gla protein gene.

Cancela L, Hsieh CL, Francke U, Price PA.

J Biol Chem. 1990 Sep 5;265(25):15040-8.

PMID:
2394711
[PubMed - indexed for MEDLINE]
Free Article
15.

Expression of Com-1/P8 in human breast cancer and its relevance to clinical outcome and ER status.

Jiang WG, Watkins G, Douglas-Jones A, Mokbel K, Mansel RE, Fodstad O.

Int J Cancer. 2005 Dec 10;117(5):730-7.

PMID:
15957166
[PubMed - indexed for MEDLINE]
16.

HER-3 overexpression is prognostic of reduced breast cancer survival: a study of 4046 patients.

Chiu CG, Masoudi H, Leung S, Voduc DK, Gilks B, Huntsman DG, Wiseman SM.

Ann Surg. 2010 Jun;251(6):1107-16. doi: 10.1097/SLA.0b013e3181dbb77e.

PMID:
20485140
[PubMed - indexed for MEDLINE]
17.

Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.

Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W.

J Pathol. 2002 Oct;198(2):181-9.

PMID:
12237877
[PubMed - indexed for MEDLINE]
18.

Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer.

Jiang WG, Douglas-Jones AG, Mansel RE.

Prostaglandins Leukot Essent Fatty Acids. 2006 Feb;74(2):125-34. Epub 2005 Dec 20.

PMID:
16364620
[PubMed - indexed for MEDLINE]
19.

[Prognostic molecular classification of breast cancers based on gene expression profiling].

Feng YM, Li XQ, Sun BC, Gao XC, Gu L, Niu Y, Hao XS.

Zhonghua Zhong Liu Za Zhi. 2006 Dec;28(12):900-6. Chinese.

PMID:
17533740
[PubMed - indexed for MEDLINE]
20.

The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer.

Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K.

Anticancer Res. 2006 Nov-Dec;26(6C):4985-90.

PMID:
17214375
[PubMed - indexed for MEDLINE]
Free Article

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk